El-Youssef Mounif
Division of Gastroenterology and Hepatology and Internal Medicine, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minn. 55905, USA.
Mayo Clin Proc. 2003 Sep;78(9):1126-36. doi: 10.4065/78.9.1126.
Wilson disease is a rare disorder of copper metabolism that results in accumulation of copper in the liver and subsequently in other organs, mainly the central nervous system and the kidneys. Advances in the diagnosis and treatment of Wilson disease are discussed, with the emphasis that this is a disease of children, adolescents, and young adults. The myriad manifestations of Wilson disease make its diagnosis dependent on a high index of suspicion, and determination of its genetic background is helping to elucidate the genotype-phenotype correlation and the diversity of presentations. Treatment of Wilson disease has progressed from chelation therapy using D-penicillamine and trientine to the more recent use of zinc and finally to the establishment of liver transplantation as an urgent but excellent modality for fulminant presentation. The evolution of Wilson disease from a uniformly fatal disease to an eminently treatable disease during the past century is an example of the remarkable advances of modern medicine.
威尔逊病是一种罕见的铜代谢紊乱疾病,会导致铜在肝脏中蓄积,随后在其他器官中蓄积,主要是中枢神经系统和肾脏。本文讨论了威尔逊病诊断和治疗方面的进展,重点强调这是一种发生于儿童、青少年和青年的疾病。威尔逊病的众多表现使其诊断依赖于高度的怀疑指数,而对其遗传背景的确定有助于阐明基因型与表型的相关性以及临床表现的多样性。威尔逊病的治疗已从使用D-青霉胺和曲恩汀的螯合疗法发展到最近使用锌,最终确立了肝移植作为暴发性表现的紧急但极佳的治疗方式。在过去的一个世纪里,威尔逊病从一种普遍致命的疾病演变为一种完全可治疗的疾病,这是现代医学取得显著进展的一个例证。